Published • loading... • Updated
Infamed Approves Funding of Two New Drugs for Neurodegenerative Disease and Brain Tumor
Summary by Jornal Expresso
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Infamed announced the conclusion of the processes of evaluation and negotiation of the medicines Skyclarys and Voranigo, creating the conditions for its prescription and use within the framework of the National Health Service
·Portugal
Read Full Article
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
